Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 98 results found. Search for [ COVID-19 vaccine BioNTech ]

Results 1 to 21 of 98
BusinessToday.In
October 20, 2020
Bill Gates says India's research and manufacturing will be critical to fighting Covid-19 especially when it comes to making vaccines at large scale; adds that vaccine development alone won't address problem as its production can throw various challenges


BusinessToday.In
October 20, 2020
Speaking during The Wall Street Journal's annual Tech Live conference on October 19, Moderna CEO Stephane Bancel said if satisfactory interim results from the study take longer to get, government authorisation of the COVID-19 vaccine may not happen until early next year


BusinessToday.In
October 19, 2020
Presently, there are around 40 different coronavirus vaccines in various stages of human clinical trials, comprising one being developed by Oxford University and AstraZeneca, which is already in an advanced stage of testing


BusinessToday.In
October 16, 2020
Pfizer and BioNTech's vaccine candidate, BNT162b2, is currently being evaluated in a global Phase 3 study ongoing at more than 120 clinical sites worldwide including the United States, Brazil, South Africa and Argentina


Reuters
October 14, 2020
While severe COVID-19 symptoms are extremely rare in infected children, they can pass on the virus to high-risk groups such as the elderly


BusinessToday.In
October 13, 2020
Johnson & Johnson sent out a document in which it stated the \"pausing rule\" has been met and the online system used to enrol patients in the study has been closed


Reuters
October 12, 2020
The government did not disclose financial terms of the deal, its first vaccine purchase, which will provide enough doses to vaccinate 750,000 people


Reuters
October 7, 2020
The FDA released the guidance laying out more stringent recommendations for drugmakers hoping to apply for an emergency use authorization (EUA) for their experimental vaccines


BusinessToday.In
October 1, 2020
Coronavirus vaccine update: In India, there are three COVID-19 vaccines under human trials--Bharat Biotech's COVAXIN, Oxford's COVDSHIELD, and Zydus Cadila's ZyCoV-D. Serum Institute has already begun a phase-3 trial of Oxford vaccine candidates at 17 sites


BusinessToday.In
September 30, 2020
COVID-19 vaccine being developed by AstraZeneca-Oxford University, Novavax, Moderna, Pfizer Inc and Johnson & Johnson are already in an advanced stage of testing


Reuters
September 30, 2020
Global competition for early coronavirus vaccine doses is already fierce, months ahead of any approvals, as wealthy countries move to secure supplies


Reuters
September 29, 2020
Alexander Gintsburg, head of the Gamaleya Institute that produced the Sputnik V vaccine said that the pace of its development was necessary under the \"wartime\" conditions of a pandemic but no corners were being cut


BusinessToday.In
September 23, 2020
Pharma giant Johnson & Johnson (J&J) has started a massive global phase 3 clinical trial with 60,000 people of its single-dose coronavirus vaccine


Reuters
September 18, 2020
In recent weeks, Pfizer has said it should know by the end of October whether the vaccine, developed together with Germany's BioNTech SE, is safe and effective


Chitranjan Kumar
September 16, 2020
The Sputnik V vaccine, developed by the Gamaleya research institute in coordination with the Russian defence ministry, is the world's first registered vaccine against COVID-19 based on the human adenoviral vectors platform


BusinessToday.In
September 16, 2020
Coronavirus vaccine trials: While China has four vaccine candidates in third or final stages of clinical trials, there are at least two companies from the United States and one from UK and Germany, which are planning to rollout vaccine before December, if everything goes as per the plan


BusinessToday.In
September 14, 2020
A Chinese virologist currently based out of Hong Kong has claimed that the new coronavirus was created in a lab in Wuhan


BusinessToday.In
September 14, 2020
The DCGI had issued a show-cause notice to Serum Institute of India on September 9 for not informing it about AstraZeneca pausing clinical trials of the vaccine candidate in other countries


Nevin John
September 13, 2020
Shell will create an Ultra club and monitor engine performance of the used cars. They are in the middle of working out a model to launch the scheme by end of the year


PTI
September 13, 2020
E-commerce companies see a large chunk of their business coming in during the festive sales and they make significant investments ahead of time to ramp up their capacity to be able to handle the spike in orders


PAGES 1 OF 5  12345